Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. <i>Cancers</i> 2020, <i>12</i>, 3426.

Weng, Ching-Fu; Huang, Chi-Jung; Huang, Shih-Hung; Wu, Mei-Hsuan; Tseng, Ailun Heather; Sung, Yung-Chuan; Lee, Henry Hsin-Chung; Ling, Thai-Yen

Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426.

Weng, Ching-Fu; Huang, Chi-Jung; Huang, Shih-Hung; Wu, Mei-Hsuan; Tseng, Ailun Heather; Sung, Yung-Chuan; Lee, Henry Hsin-Chung; Ling, Thai-Yen.

Afiliação

Weng CF; Division of Pulmonary Medicine, Department of Internal Medicine, Hsinchu Cathay General Hospital, Hsinchu 300, Taiwan.
Huang CJ; Department and Graduate Institute of Pharmacology, National Taiwan University, Taipei 100, Taiwan.
Huang SH; Medical Research Center, Cathay General Hospital, Taipei 106, Taiwan.
Wu MH; Department of Biochemistry, National Defense Medical Center, Taipei 114, Taiwan.
Tseng AH; School of Medicine, Fu Jen Catholic University, New Taipei 242, Taiwan.
Sung YC; Division of Pathology, Cathay General Hospital, Taipei 106, Taiwan.
Lee HH; Teaching and Research Center, Hsinchu Cathay General Hospital, Hsinchu 300, Taiwan.
Ling TY; Department of Biomedical Sciences and Engineering, National Central University, Taoyuan 320, Taiwan.

Cancers (Basel) ; 13(16)2021 Aug 10.

Article em En | MEDLINE | ID: mdl-34439403

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google